Search - tctmd.com

Displaying 1 - 5 of 5

Sort: Relevancy | Date

Updateon PCS K-9 Inhibition

Presentation Controversies and Advances 2018

Updateon PCS K-9 Inhibition

Presenter: P.K. Shah

November 15, 2018

PCSK9 Inhibitors - Are They Worth The Money?

Presentation Controversies and Advances 2017

PCSK9 Inhibitors - Are They Worth The Money?

Presenter: Michael J. Blaha

November 16, 2017

From Andreas Gruentzig to PCSK9: How Angioplasty Transformed Cardiovascular Care

Presentation CDM 2017

From Andreas Gruentzig to PCSK9: How Angioplasty Transformed Cardiovascular Care

Presenter: Spencer B. King

October 06, 2017

Can Heart Disease be Eventually Abolished? The PCSK9 Revolution

Presentation CDM 2017

Can Heart Disease be Eventually Abolished? The PCSK9 Revolution

Presenter: Robert A. Vogel

October 06, 2017

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Presentation ESC 2017

Clinical Efficacy and Safety of Achieving Very Low LDL-C Levels With the PCSK9 Inhibitor Evolocumab in the FOURIER Outcomes Trial

Presenter: Robert Giugliano

August 28, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.